Açıklama
Robustness check (Figure 137) from the mediation Mendelian randomization analysis, validating the omega-3 PUFA and IBD causal pathway using weighted median or MR-Egger methods.
Figure 137
ChartSource Paper
Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bowel Disease via Circulating Metabolites: A Mediation Mendelian Randomization Study.Cite This Figure
![Figure 137: Robustness check (Figure 137) from the mediation Mendelian randomization analysis, validating the omega-3 PUFA and IBD causal pathway using weighted median or MR-Egger methods.]() > Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." *Metabolites*, 2023. PMID: [37887366](https://pubmed.ncbi.nlm.nih.gov/37887366/)
<figure> <img src="" alt="Robustness check (Figure 137) from the mediation Mendelian randomization analysis, validating the omega-3 PUFA and IBD causal pathway using weighted median or MR-Egger methods." /> <figcaption>Figure 137. Robustness check (Figure 137) from the mediation Mendelian randomization analysis, validating the omega-3 PUFA and IBD causal pathway using weighted median or MR-Egger methods.<br> Source: Xiaojing Jia et al. "Evaluating the Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Bo." <em>Metabolites</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37887366/">37887366</a></figcaption> </figure>